VARIANT II TURBO LINK HEMOGLOBIN A1C PROGRAM, AND VARIANT II TURBO LINK HEMOGLOBIN TESTING WITH MODEL, 270-2716,

Assay, Glycosylated Hemoglobin

BIO-RAD LABORATORIES INC., CLINICAL SYSTEMS DIVISI

The following data is part of a premarket notification filed by Bio-rad Laboratories Inc., Clinical Systems Divisi with the FDA for Variant Ii Turbo Link Hemoglobin A1c Program, And Variant Ii Turbo Link Hemoglobin Testing With Model, 270-2716,.

Pre-market Notification Details

Device IDK070819
510k NumberK070819
Device Name:VARIANT II TURBO LINK HEMOGLOBIN A1C PROGRAM, AND VARIANT II TURBO LINK HEMOGLOBIN TESTING WITH MODEL, 270-2716,
ClassificationAssay, Glycosylated Hemoglobin
Applicant BIO-RAD LABORATORIES INC., CLINICAL SYSTEMS DIVISI 4000 ALFRED NOBEL DR. Hercules,  CA  94547
ContactJackie H Buckley
CorrespondentJackie H Buckley
BIO-RAD LABORATORIES INC., CLINICAL SYSTEMS DIVISI 4000 ALFRED NOBEL DR. Hercules,  CA  94547
Product CodeLCP  
CFR Regulation Number864.7470 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2007-03-26
Decision Date2007-06-25
Summary:summary

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
00847817014901 K070819 000
00847817014895 K070819 000
00847817014888 K070819 000
00847817014871 K070819 000
00847817014833 K070819 000
00847817008580 K070819 000
00847817000119 K070819 000
00847817000010 K070819 000
00847817000003 K070819 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.